Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF – Get Free Report) was down 6.7% on Thursday . The company traded as low as $13.77 and last traded at $14.97. Approximately 1,259 shares traded hands during trading, a decline of 47% from the average daily volume of 2,373 shares. The stock had previously closed at $16.05.
Kyowa Kirin Stock Performance
The firm’s fifty day moving average price is $16.87 and its 200-day moving average price is $18.36.
About Kyowa Kirin
Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.
Read More
- Five stocks we like better than Kyowa Kirin
- Top Stocks Investing in 5G Technology
- Micron Stock Under $100: Seize the AI-Driven Upside
- Using the MarketBeat Dividend Tax Calculator
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
